These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 1984460
1. Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. Arciniega JL, Hewlett EL, Johnson FD, Deforest A, Wassilak SG, Onorato IM, Manclark CR, Burns DL. J Infect Dis; 1991 Jan; 163(1):135-42. PubMed ID: 1984460 [Abstract] [Full Text] [Related]
2. Antibodies to Bordetella pertussis adenylate cyclase toxin in neonatal and maternal sera. Arciniega JL, Hewlett EL, Edwards KM, Burns DL. FEMS Immunol Med Microbiol; 1993 Apr; 6(4):325-30. PubMed ID: 8499896 [Abstract] [Full Text] [Related]
3. Detection of antibodies against fimbria type 3 (Fim3) is useful diagnostic assay for pertussis. Oguchi K, Miyata A, Kazuyama Y, Noda A, Suzuki E, Watanabe M, Nakayama T. J Infect Chemother; 2015 Sep; 21(9):639-46. PubMed ID: 26134278 [Abstract] [Full Text] [Related]
4. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis. Ausiello CM, Urbani F, La Sala A, Lande R, Piscitelli A, Cassone A. Dev Biol Stand; 1997 Sep; 89():315-20. PubMed ID: 9272365 [Abstract] [Full Text] [Related]
5. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France. Grimprel E, Bégué P, Anjak I, Njamkepo E, François P, Guiso N. Clin Diagn Lab Immunol; 1996 Jan; 3(1):93-7. PubMed ID: 8770511 [Abstract] [Full Text] [Related]
6. Western blot analysis of antibody responses of young infants to pertussis infection. Guiso N, Grimprel E, Anjak I, Bégué P. Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):596-600. PubMed ID: 8223658 [Abstract] [Full Text] [Related]
7. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens. Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J. Vaccine; 2004 Oct 22; 22(31-32):4270-81. PubMed ID: 15474718 [Abstract] [Full Text] [Related]
8. [A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine]. Zakharova NS, Shmeleva EI, Remova TN, Bazhanova IG, Ozeretskovskaia MN, Mertsalova NU, Britsina MV, Ermolova EV, Zaĭtsev EM. Zh Mikrobiol Epidemiol Immunobiol; 1997 Oct 22; (3):70-2. PubMed ID: 9304336 [Abstract] [Full Text] [Related]
9. Immune responses to Bordetella pertussis infection and vaccination. Tomoda T, Ogura H, Kurashige T. J Infect Dis; 1991 Mar 22; 163(3):559-63. PubMed ID: 1995729 [Abstract] [Full Text] [Related]
10. Serological responses to infection with B. pertussis. Giammanco A, Taormina S, Genovese M, Mangiaracina G, Giammanco G, Chiarini A. Dev Biol Stand; 1997 Mar 22; 89():213-20. PubMed ID: 9272353 [Abstract] [Full Text] [Related]
11. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB. Clin Infect Dis; 1999 Mar 22; 28(3):552-9. PubMed ID: 10194077 [Abstract] [Full Text] [Related]
12. Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice. Hormozi K, Parton R, Coote J. FEMS Immunol Med Microbiol; 1999 Apr 22; 23(4):273-82. PubMed ID: 10225286 [Abstract] [Full Text] [Related]
13. Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussis. Eby JC, Gray MC, Warfel JM, Merkel TJ, Hewlett EL. Clin Vaccine Immunol; 2017 Jan 22; 24(1):. PubMed ID: 27760780 [Abstract] [Full Text] [Related]
14. Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis. Cherry JD, Xing DX, Newland P, Patel K, Heininger U, Corbel MJ. Clin Infect Dis; 2004 Feb 15; 38(4):502-7. PubMed ID: 14765342 [Abstract] [Full Text] [Related]
15. Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination. Thomas MG, Redhead K, Lambert HP. J Infect Dis; 1989 Feb 15; 159(2):211-8. PubMed ID: 2536779 [Abstract] [Full Text] [Related]
16. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Edwards KM, Meade BD, Decker MD, Reed GF, Rennels MB, Steinhoff MC, Anderson EL, Englund JA, Pichichero ME, Deloria MA. Pediatrics; 1995 Sep 15; 96(3 Pt 2):548-57. PubMed ID: 7659475 [Abstract] [Full Text] [Related]
17. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice. Orr B, Douce G, Baillie S, Parton R, Coote J. Vaccine; 2007 Jan 02; 25(1):64-71. PubMed ID: 16916566 [Abstract] [Full Text] [Related]
18. Japanese clinical trials with Takeda acellular pertussis vaccine. Kuno-Sakai H, Kimura M, Ozaki K, Isomura S, Kamiya H, Nii R, Kato T, Horiuchi K, Syukuda Y, Fujita I. Tokai J Exp Clin Med; 1988 Jan 02; 13 Suppl():15-9. PubMed ID: 2908519 [Abstract] [Full Text] [Related]
19. Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccination. Farfel Z, Könen S, Wiertz E, Klapmuts R, Addy PA, Hanski E. J Med Microbiol; 1990 Jul 02; 32(3):173-7. PubMed ID: 2374155 [Abstract] [Full Text] [Related]
20. Secretory IgA against pertussis toxin and surface structures of Bordetella pertussis in saliva of children with culture proven pertussis. Frühwirth M, Wolf H, Heininger H, Guggenbichler JP, Stehr E. Adv Exp Med Biol; 1995 Jul 02; 371B():777-83. PubMed ID: 7502896 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]